Recall
FDAHealthApril 3, 2025

Zydus Pharmaceuticals (USA) Inc — chlorproMAZINE Hydrochloride Tablets, USP 10 mg, Rx Only, 100 Tablets bottles, Manufactured by: Zydus Lifesciences Ltd., Baddi, India, Distributed by: Zydus Pharmaceu

⚠️ CGMP deviations: presence of N-Nitroso-Desmethyl Chlorpromazine impurity above the recommended interim limit

Is this relevant to me?

Geography
Nationwide
Source agency
FDA
Category
Health
Published
April 3, 2025

Nationwide within U.S - MS, AL, TN, VT, OH, ND, MN, WI, SC, AR, FL, IN, LA, NJ, AZ, TX, KY and PA

What's affected?

Product
chlorproMAZINE Hydrochloride Tablets, USP 10 mg, Rx Only, 100 Tablets bottles, Manufactured by: Zydus Lifesciences Ltd., Baddi, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 70710-1129-1
UPC
0370710112912
Lot code
Z400069

Additional details

Lot #: Z400069, Exp.: 12/31/2025

What should I do?

Recommended action

Class II recall. Voluntary: Firm initiated Quantity affected: 3144 bottles, pack size: 100's Count.

View original FDA notice →

Get Health recall alerts

Delivered to your inbox. Free. No account required.